XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings (Loss) Per Common Share
9 Months Ended
Sep. 30, 2024
Earnings (Loss) Per Common Share [Abstract]  
Earnings (Loss) Per Common Share

Note 9.
Earnings (Loss) Per Common Share



A reconciliation of the numerator and denominator used in the earnings (loss) per common share calculations is as follows:


   
Three Months Ended
September 30, 2024
 
   
Loss
   
Weighted
Average Shares
(In thousands)
   
Per Share
Amount
 
Basic and Diluted Loss Per Common Share:
                 
Net loss
  $ (1,998 )     20,400
   

 
Less preferred stock dividends
    (100 )    
         
Net loss applicable to common shareholders
  $ (2,098 )     20,400
    $ (0.10 )


   
Three Months Ended
September 30, 2023
 
    Income
   
Weighted
Average Shares
(In thousands)
   
Per Share
Amount
 
Basic Earnings Per Common Share:
                 
Net income
  $ 1,759       20,402        
Less preferred stock dividends
    (100 )            
Net income applicable to common shareholders
  $ 1,659       20,402     $ 0.08  
Diluted Earnings Per Common Share:                        
Effect of Series D preferred stock     100       1,378          
   Net income applicable to common shareholders   $ 1,759       21,780     $ 0.08  

   
Nine Months Ended
September 30, 2024
 
   
Loss
   
Weighted
Average Shares
(In thousands)
   
Per Share
Amount
 
Basic and Diluted Loss Per Common Share:
                 
Net loss
  $ (4,680 )     20,401
   
   
Less preferred stock dividends
    (299 )    
         
Net loss applicable to common shareholders
  $ (4,979 )     20,401
    $ (0.24 )

   
Nine Months Ended
September 30, 2023
 
   
Income
   
Weighted
Average Shares
(In thousands)
   
Per Share
Amount
 
Basic and Diluted Earnings Per Common Share:
                 
Net income
  $ 2,057       20,405
   
   
Less preferred stock dividends
    (299 )    
         
Net income applicable to common shareholders
  $ 1,758       20,405
    $ 0.09  


The assumed conversion of the Company’s Series D preferred stock was excluded from the earnings (loss) per common share calculation for all periods presented, except for the three month period ended September 30, 2023, since its impact would have been antidilutive.